{"ticker": {"uuid": "d1ccf406-7ef3-46a1-9dbc-c01f7026442f", "symbol": "PAVM", "name": "PAVmed Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Price to book forward of PAVmed Inc. \u2013 NASDAQ:PAVM", "summary": "The article focuses on the \"Price to book forward\" financial metric for PAVmed Inc. (NASDAQ: PAVM). It appears to be a financial data page from TradingView, providing an overview of this specific valuation ratio for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T08:43:38", "published_display": "08 Jul 2026 08:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of PAVmed Inc. \u2013 NASDAQ:PAVM", "summary": "This page provides financial information for PAVmed Inc. (NASDAQ: PAVM) on TradingView, specifically focusing on the company's forward price to sales ratio. It lists the stock on the Nasdaq Stock Market and appears to be a stub or an incomplete data presentation, indicating \"No t", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T10:41:28", "published_display": "07 Jul 2026 10:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of PAVmed Inc. \u2013 NASDAQ:PAVM", "summary": "The article focuses on the \"Price to earnings forward\" metric for PAVmed Inc. (NASDAQ: PAVM). It appears to be a financial data snippet from TradingView, indicating that the market for PAVM is currently closed with no trades recorded.", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T00:39:54", "published_display": "07 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed gets 180-day extension to regain Nasdaq listing compliance", "summary": "PAVmed has been granted a 180-day extension by Nasdaq to regain compliance with its listing requirements. This extension provides the medical device company additional time to meet the necessary criteria to maintain its listing on the exchange. The news indicates a temporary repr", "url": "https://www.msn.com/en-us/money/topstocks/pavmed-gets-180-day-extension-to-regain-nasdaq-listing-compliance/ar-AA1JzUnl?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-04T06:39:54", "published_display": "04 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed, Inc. Financial Disclosures & Filings", "summary": "This article provides a comprehensive list of PAVmed, Inc.'s financial disclosures and regulatory filings, organized by fiscal year and quarter. It includes links to earnings call transcripts, earnings releases, quarterly and annual reports (10-Q and 10-K), and presentation slide", "url": "https://www.tradingview.com/symbols/FWB-1P5/documents/", "source_name": "TradingView", "published_at": "2026-07-03T07:10:23", "published_display": "03 Jul 2026 07:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of PAVmed Inc. \u2013 NASDAQ:PAVM", "summary": "This article provides an overview of PAVmed Inc. (NASDAQ: PAVM) focusing on its enterprise value to revenue forward metric. It appears to list financial data and market information through the TradingView platform. The content is primarily a listing of financial data access rathe", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T08:11:52", "published_display": "01 Jul 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc.(NasdaqCM: PAVM) added to Russell Microcap Value Benchmark Index", "summary": "PAVmed Inc. (NasdaqCM: PAVM), a commercial-stage medical technology company, has been added to the Russell Microcap Value Benchmark Index. This inclusion follows its prior addition to the Russell 3000E Index and the Russell Microcap Index. The company operates in medical devices,", "url": "https://www.marketscreener.com/news/pavmed-inc-nasdaqcm-pavm-added-to-russell-microcap-value-benchmark-index-ce7f5fded080ff25", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T13:14:37", "published_display": "29 Jun 2026 13:14", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc.(NasdaqCM: PAVM) added to Russell 3000E Value Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmFuaGxVS2JnSG5TV2YwVGZWejlnSXo3OEJWdmxWdE5RUXVISjYxcGlXTGNBUHgxSGJ4TTFjbHI5MFNUdFhQanVDaUNEc3RYLUFtdFQwdzFpX2Frc1Jqdzd6UXFKdGt3RldvRlF3bVg0V3hjN29vajVGVkZTa194OGUxUE9EcVU3MUE5bmd2VTA5UUFyR0J0V3k3U0cxRDJlc1pRVTlQNEREUGVxWVFrY3c1Z3Z3OVk?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed, Inc. Actuals & Estimates (NASDAQ:PAVM)", "summary": "This article provides an overview of PAVmed Inc. (NASDAQ: PAVM) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, financial actuals and estimates, upcoming earnings dates, and past earnings and revenue figures. Th", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:47", "published_display": "26 Jun 2026 03:40", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for PAVmed Inc. (PAVM) stock for 2027, based on analyst opinions. It details the current stock price, historical performance, volatility, market capitalization, and upcoming earnings report. The article also includes frequently as", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:40:47", "published_display": "25 Jun 2026 14:40", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed (PAVM) holders re-elect directors, expand ESPP shares and ratify CBIZ", "summary": "PAVmed Inc. shareholders re-elected directors Ronald M. Sparks and Timothy Baxter and approved significant amendments to the Employee Stock Purchase Plan (ESPP), increasing available shares and the annual evergreen limit. Additionally, shareholders ratified CBIZ CPAs P.C. as the ", "url": "https://www.stocktitan.net/sec-filings/PAVM/8-k-pa-vmed-inc-reports-material-event-a905a8c4bac2.html", "source_name": "Stock Titan", "published_at": "2026-06-24T21:09:59", "published_display": "24 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of PAVmed Inc (PAVM), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock has a current price momentum score of 7.15 and is trading between a resistance level of 6.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/technical", "source_name": "TradingKey", "published_at": "2026-06-23T07:39:25", "published_display": "23 Jun 2026 07:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article analyzes the financial health of PAVmed Inc (PAVM), noting its stable financial status but low operational efficiency. As of June 18, 2026, its financial score is 7.21, ranking 101 out of 203 in the Healthcare Equipment & Supplies industry. The company reported a sig", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/financial-health", "source_name": "TradingKey", "published_at": "2026-06-19T11:10:20", "published_display": "19 Jun 2026 11:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVMZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of PAVmed Inc (PAVMZ), covering its support, resistance, indicators, and moving averages. It notes that relevant data for support and resistance have not yet been disclosed by the company. The analysis indicates a \"Sell\" signal based on ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavmz/technical", "source_name": "TradingKey", "published_at": "2026-06-18T23:40:46", "published_display": "18 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Institutional Confidence", "summary": "This article provides details on PAVmed Inc (PAVM)'s institutional confidence, highlighting its stock price, market cap, and a breakdown of its TradingKey Stock Score, which includes institutional confidence. It lists key institutional shareholders and their shareholdings. The da", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T23:39:03", "published_display": "18 Jun 2026 23:39", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVMZ) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article provides an analysis of PAVmed Inc's (PAVMZ) financial health, focusing on profitability and its balance sheet. However, the report indicates that relevant financial data for key metrics such as cash and cash equivalents, total assets, liabilities, free cash flow, re", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavmz/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T22:40:46", "published_display": "18 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of PAVmed Inc's (PAVM) dividend history and stock split events. It indicates that PAVmed has not distributed any dividends in the past five years. The article also lists several stock split events, all described as \"Merger\" type, with the most re", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T22:40:46", "published_display": "18 Jun 2026 22:40", "sentiment": "negative", "sentiment_pct": 42, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of PAVmed Inc (PAVM), listing major individual and institutional holders and their respective proportions. It also presents a historical overview of institutional shareholding by reporting period, as well as recent shareholder activi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T15:39:45", "published_display": "18 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for PAVmed Inc (PAVM), detailing its current earnings forecast score, analyst ratings, and price targets. It notes that PAVmed Inc has an earnings forecast score of 8.00, ranks 66th in its industry, and has an average price target of $12", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T12:39:45", "published_display": "18 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey attempts to provide a revenue breakdown for PAVmed Inc (PAVM) by business segments and regional contributions. However, the company has not disclosed the relevant financial data. Therefore, the article primarily highlights the unavailability of this s", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T08:39:45", "published_display": "18 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVMZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "The article discusses the revenue breakdown of PAVmed Inc (PAVMZ) but explicitly states that relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. Therefore, the content highlights the lack of publicly ava", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavmz/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T15:10:13", "published_display": "17 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVMZ) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides an overview of PAVmed Inc's (PAVMZ) shareholder structure, highlighting that \"Other\" shareholders account for 100% of the proportional holdings. It also details institutional shareholding data from Q3 2023 to Q3 2025, showing changes in the number of institu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavmz/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T07:10:13", "published_display": "17 Jun 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PAVM Maintains Buy Rating -- Price Target Lowered to $56.00 by Ascendiant Capital", "summary": "Ascendiant Capital has maintained a \"Buy\" rating for PAVmed Inc (PAVM) but lowered its price target from $65.00 to $56.00, representing a 13.85% decrease. Despite the maintained buy rating, GuruFocus indicates that PAVM is significantly overvalued with a GF Value\u2122 of $1.28 agains", "url": "https://www.gurufocus.com/news/8904895/pavm-maintains-buy-rating-price-target-lowered-to-5600-by-ascendiant-capital", "source_name": "GuruFocus", "published_at": "2026-06-08T10:39:19", "published_display": "08 Jun 2026 10:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM - PAVmed Inc Stock Price and Quote", "summary": "This article provides comprehensive stock information for PAVmed Inc. (PAVM), including its current stock price, financial metrics, performance indicators, and recent news and analyst ratings. It also details the company's business activities, focusing on its Lucid Diagnostics an", "url": "https://finviz.com/stock?t=PAVM", "source_name": "Finviz", "published_at": "2026-06-02T16:39:46", "published_display": "02 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPZ1dYQ3MyTGgtVWNsNUtETFl0R3hZWmdFdWhadnR0SGtfSmdBN1JIQ0xaaXd6OU1yTVk1RU1SY0RGUHdpTHdFU2pKUkYyeEw4NFpnWmlBRVJTTXEydzA4Sk9mUS1kQXp4T2tPSi1FUnVuNDdpRUxMalZpYWlGbmQ0NXY2cFB4WGxUb2o0ZTVQazVXcTM2ZkoydXgxTGpnQzFGUmFWTkJ0UQ?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc. (PAVM) Holds Steady Near Support as Slight Dip Signals Consolidation - Intraday Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNWFFUX29WREgwTV82NnAyQVZVUnNmdDBEaFZnaE1MVExjdkxZVnlPN1pmc2tnbzc2anZfQ204dkZBNE1sdU5Hd0tkX1Y3bDZvaVI5SUoyX1Fhc0lFVGxDOTFuaGRRcFZUbkp1TWR3MTFUZ0pzRXBOb2RoS29iNkljUEZvZzJvcVphMVc0czN3SWM1Rm5jU0QyczZRMDRHQzFHYkhZZlcwUHdIdG1ibUVQTDUtVFU4dGZyWEJGSmFn?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis of PAVmed Inc (PAVM), concluding with a \"Strong Sell\" consensus based on various indicators. It details moving averages, momentum indicators like RSI and MACD, and identifies key support and resistance levels. The analysis highlights tha", "url": "https://intellectia.ai/en/stock/PAVM/technical", "source_name": "Intellectia AI", "published_at": "2026-05-28T01:38:45", "published_display": "28 May 2026 01:38", "sentiment": "negative", "sentiment_pct": 8, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM PE Ratio & Valuation, Is PAVM Overvalued", "summary": "This article analyzes the valuation of PAVmed Inc (PAVM), concluding that it is currently overvalued. Based on relative valuation methods, PAVM's fair price is estimated to be between $2.40 and $5.27, compared to its current price of $6.35, indicating a 20.39% overvaluation. The ", "url": "https://intellectia.ai/en/stock/PAVM/valuation", "source_name": "Intellectia AI", "published_at": "2026-05-22T19:09:23", "published_display": "22 May 2026 19:09", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM|PAVmed Inc|Price:6.390|Chg%:0.04", "summary": "PAVmed Inc (PAVM) shows stable fundamentals, industry-leading ESG disclosure, and high growth potential, though its valuation is only fairly valued within its industry. Analyst ratings are \"Buy\" with a target price of $40.50, despite recent weak market performance. The company sp", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm", "source_name": "TradingKey", "published_at": "2026-05-22T12:08:58", "published_display": "22 May 2026 12:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Maintains Target Price $16", "summary": "Maxim Group has reiterated its Buy rating for PAVmed (PAVM.US) and maintained its target price at $16. This indicates continued confidence from the analyst firm in the company's prospects.", "url": "https://www.moomoo.com/news/post/70260820/maxim-group-maintains-pavmed-pavmus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-05-21T11:39:22", "published_display": "21 May 2026 11:39", "sentiment": "positive", "sentiment_pct": 78, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings call transcript: PAVmed Q1 2026 sees restructuring gains", "summary": "PAVmed Inc. (PAVM) reported mixed financial results for Q1 2026, featuring significant capital structure improvements from a recent recapitalization despite a stock decline. The company is actively relaunching its medical device portfolio, pursuing new assets, and advancing its s", "url": "https://m.in.investing.com/news/stock-market-news/earnings-call-transcript-pavmed-q1-2026-sees-restructuring-gains-93CH-5419116?ampMode=1", "source_name": "Investing.com India", "published_at": "2026-05-20T23:11:49", "published_display": "20 May 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Q1: cancer test and implantable monitor push toward coverage, FDA", "summary": "PAVmed reported Q1 2026 financial results with a GAAP net loss of $7.0 million, and non-GAAP adjusted net loss of $1.9 million, while cash and equivalents increased to $6.5 million. The company's subsidiary, Lucid Diagnostics, generated $1.3 million in EsoGuard revenue and secure", "url": "https://www.stocktitan.net/news/LUCD/pa-vmed-provides-business-update-and-reports-first-quarter-2026-th0qvi03ua1b.html", "source_name": "Stock Titan", "published_at": "2026-05-19T06:40:13", "published_display": "19 May 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pavmed-inc-pavm-q1-2026-230154477.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T23:01:54+00:00", "published_display": "15 May 2026 23:01", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed (PAVM) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/7721d31f-8283-3dd3-98c4-aff0fcc13c2e/pavmed-%28pavm%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-15T15:36:59+00:00", "published_display": "15 May 2026 15:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed (PAVM) Q4 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/841b463c-3916-3223-a706-0fd27ecc3451/pavmed-%28pavm%29-q4-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-15T15:36:20+00:00", "published_display": "15 May 2026 15:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/pavmed-inc-pavm-reports-q1-131502431.html", "source_name": "Zacks", "published_at": "2026-05-15T13:15:02+00:00", "published_display": "15 May 2026 13:15", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNNnkwNXhpZmVHRHZBWDhoQzB1SWxaQkRUbDJ4NEllRm9IQm1VclJTZkVKSmloYUQta2ZPTXBGUWNaUjhicUs2T3ltYWJOV3o2b0JsdEt2YUw0cC1neFdBT2ZubjZNa2J5Zk5NeTdyd3hvclNoUVlUcUVrRGNoUG51cmVqQ1lWX2t3ZDlFaDh2YTlYUGxBcFhIdTRfQWQ3UXZNQ2ZFMWlIbmdtcjRJVFZ4Vlc2c1RSVGM0eGYzT01WQWxJbUd1X3BrZFpwMjM3M01reWc?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOVGkyQno5anU4TkRPQW03WWdXT1UtaWcxX3NGdnFVZlFINHE3clRtb3hpTFlxQVhxd1ZzNVd2bWNoY1NXblNQNTlCMXRRVkp4azh3TlkxV2Znb1BNWEw1Qm1fMHhnQ05RVXlXQTJYX01VendtNVZPc2FwUlIzbGExckJjbHhjNmM3cDJVUUYxdw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNbXpmeHlSbks3aVlPMF9FNjQ5UFdGY2huU2tNc2Q1emFkX2pvd0RjZWNMQ2hSNy1PYmFrSDVYd2szV3c0WVBCLXZZQ0Z2N2w5TjdsUHdQV2szdzZab1pyUWx3YUdpbFhkck1oVFp3Rm04aHNJWnN3TWc0SHRhRzd3WFdDVi0wQU9CbXpBQzVZX2RWUQ?oc=5", "source_name": "TipRanks", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Shares Soar Amid Strategic Developments and Market Reactions", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE5UdEpqLU1JdGUzc0dvTWxJdzUwX3hzV01fU2RxRUtqUUIwd3dlZDVsMXdXbnVhSmhqREJVSnpPeDJoQTdYc3YzeHF6bVpsLW80SDRGT2ZMRi1FaDdZd2k5bjVOMzFCZ0N1RUlKN3hGWV8wZGc4?oc=5", "source_name": "timothysykes.com", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should you chase the rally in PAVmed stock that quadrupled on Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNdC1fc3FxQlRqWWJGamtoRy05Q3hacHNjY2loN3N5WWxvWkxYdGJUUGRuSlJaWk9zcy1xdWdLaUV0Q0pZMmhCZzJZbGpnLUJ6WVZMdVFBUzRmWkRVVW0xZnQ2X3VCdHpwOVZ3NTFPdHZNdjc0ekE0NjBTcVpQT0ZFaVZpUmItUXVsZ1RGQ1dOcFFJbThVSE1VaF9ZX2kyNlB4RTZDSlRLcFFObGZXWFlTOQ?oc=5", "source_name": "Invezz", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Announces Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNdWFwWWZQRUtOUndpYUpMZzh6anJlOUxJUGtLdHVHRjhCZVJLaFNfN3k5SDJReDNfOUlsNjdMV0hoYmZlN3BKYWhranhCWDVFQ2xhbzJPdEJ6OGZwdXh3ckE3TndfYlBkSzVUM2NaWDhQbnA3RUVaSlU3SEtPSHZwZk5zUjYyQm1HRkowdnhva0hjR0JacHRn?oc=5", "source_name": "PR Newswire", "published_at": "2025-12-30T08:00:00+00:00", "published_display": "30 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed stock drops after announcing 1-for-30 reverse split", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQTmpVUXlSWnZXcG9EeWVtV1Zzb0ZQTFJVQ21KQ3dnNF84cml5MHM2c3BoUzVUOXNtRWo5RUg3X280TlhaMnV3ekxqbzU1anVYYncxVUlMN09NdDVpRjhzZ2RUMEE4aGFGOW9renpkb0twSjlDSUNYNE5wb0ZkbUo0Um1Za0x6YlVGZEs0Z2s2Q2RGZGJ1SncxcHVDSlVLekFBUUQ4SVE4M0J3M2FETnVnaEhvZE1iT0xMZ2c?oc=5", "source_name": "Investing.com", "published_at": "2025-12-30T08:00:00+00:00", "published_display": "30 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is PAVmed (NASDAQ:PAVM) Using Debt Sensibly?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZ1U2TWRSQzFTcVh2WXh6WkJiTmpoQTZFNndhcXpNTUFQcnN3Tk1uaXJQeExZZl92RDJaaFM1cE1sbkdwaXJfaklfclU0R0JrVmlRN0phNFlVTnpaNUo4bk1YeU4xYU1oX2cxMkU3a1dmeXh0bHhBTFZreWF6WlhHTzM0U2dDSUpoaE9fS2JMMW9YeGNCYXNNQ2ozRzVTTWdlbGh4bFc0TkFsbnfSAbABQVVfeXFMT25MaGdfZEJpLVF2dWViWVc4Mnk0blFNX2tVaFkzVnk2XzRZdGpaZS1kcjE2R05LQzR4REFVcGFSTDVqV0RsQ24zVjRQbWJPSXQ5ZjRjU0JMWW9BSHJhMjhCTjhNUlVGeVZMYktUN2F3emtiRDhpWmdaRFFJRkxTcEJ0ejQxOENWMFFXWDFLZFd1QzVZeUd1OXlKb3FYSFJpNS01OXJoQ2p2Z0tMODBuSGI?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-18T08:00:00+00:00", "published_display": "18 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed (PAVM) Upgraded to Strong Buy: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQckh5WWQ0T2lJTm4zUTNtbVA4RFpCRXYzVGpHWXI1NHNsMmJfdTBxNFIzb0R6Ql9HVnJjSzdrYVlWM3d6c3Q5R3hrbnU2UFNkUzNKYi1oQnA3QkloZkV1c0U4emJZTVBWbGs4dmFiUFZTZHRaZ29xbjBkNkwyYjRiVVpuYw?oc=5", "source_name": "Market source", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxQb0tUdlFLZHNlR1dCb0hsTHJQVTMzQjdTSWl3bnR4T1VZQi13ajdRQTVUVUFQRFBabzBLV1JERi1VWjhIVHc4elJHOTRmM2xxTDVxTGlMdC02SWNoZDRNaG1ucnd2Z01yNTA2X0RTSEN4MVA3SHRkRFJqVFdwZVI1UWJtWHB4RG1BNlByNEtGTDFkaHNlSkpfWTZKOTA5YUlnX3hULXhqYjlZTFFRZmhNQnVOZzcyd2puUHBBSE90RkhEak4zOHVhMG9fbS1OQlRTZ2tSQkJ6dlVzM29idmpPOWhvNUxGRFNidTdyelZKWnd0UF93dHhlb09lWFpOYlBLUzRGbDlURkxpeTQ5N095dGlOS3M3S0kyenJHbVp5dUdCME9XcGJqVk5aNA?oc=5", "source_name": "PR Newswire", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQVmdnZ1lZUUpXcjhBOEtHb2d0anZTS0VxQWhLRlpld2RmTE1XNlZ0c00xRkxBak1ndmpPZWd1QmFOeEJuTVhYSnkyblRCTVFJaGVCa24wdC1zcmFOQkVNa2NGRXBCd2JsbWNOR1JFWmc3ZGtzRHNrdzhPRGJYSlNtRC1PUUNXNEdhS1c1UUpUbENESS00NDlUcHVtT3B1YzNoNGRzelBOWFJPUC1KV2IxNmdMNHV6YXZzVHF1YUY5b3hNQ29VX2ZXTWVtWGtQNlFhWHplUHJR?oc=5", "source_name": "PR Newswire", "published_at": "2023-12-04T08:00:00+00:00", "published_display": "04 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pavmed (PAVM) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9PTVpfWEk3Wmo0Q0xjTGFqNi0wQm0wZkJHRm9UV1BYcEtScGNZU01CaEtrRlNEU1dkQWZRenNRQVZWdWdSSmwwT1dfSU1CUQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-09-12T01:53:59+00:00", "published_display": "12 Sep 2020 01:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM Stock Price and Chart \u2014 NASDAQ:PAVM", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE4xaVl2aXA4cnEtTGNaSUtTTUNhZW9GTEo3X1lYZzAzYndkQTRBVjRUdmtVcjlPYk5nQUVtQ25fNnFUZTZxcnJKYW0tdTNvanVoSWNjTC1MTk1IZFFS?oc=5", "source_name": "TradingView", "published_at": "2017-08-04T22:59:47+00:00", "published_display": "04 Aug 2017 22:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to book forward of PAVmed Inc. \u2013 NASDAQ:PAVM", "summary": "The article focuses on the \"Price to book forward\" financial metric for PAVmed Inc. (NASDAQ: PAVM). It appears to be a financial data page from TradingView, providing an overview of this specific valuation ratio for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T08:43:38", "published_display": "08 Jul 2026 08:43", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of PAVmed Inc. \u2013 NASDAQ:PAVM", "summary": "This page provides financial information for PAVmed Inc. (NASDAQ: PAVM) on TradingView, specifically focusing on the company's forward price to sales ratio. It lists the stock on the Nasdaq Stock Market and appears to be a stub or an incomplete data presentation, indicating \"No t", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T10:41:28", "published_display": "07 Jul 2026 10:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of PAVmed Inc. \u2013 NASDAQ:PAVM", "summary": "The article focuses on the \"Price to earnings forward\" metric for PAVmed Inc. (NASDAQ: PAVM). It appears to be a financial data snippet from TradingView, indicating that the market for PAVM is currently closed with no trades recorded.", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T00:39:54", "published_display": "07 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed gets 180-day extension to regain Nasdaq listing compliance", "summary": "PAVmed has been granted a 180-day extension by Nasdaq to regain compliance with its listing requirements. This extension provides the medical device company additional time to meet the necessary criteria to maintain its listing on the exchange. The news indicates a temporary repr", "url": "https://www.msn.com/en-us/money/topstocks/pavmed-gets-180-day-extension-to-regain-nasdaq-listing-compliance/ar-AA1JzUnl?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-04T06:39:54", "published_display": "04 Jul 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed, Inc. Financial Disclosures & Filings", "summary": "This article provides a comprehensive list of PAVmed, Inc.'s financial disclosures and regulatory filings, organized by fiscal year and quarter. It includes links to earnings call transcripts, earnings releases, quarterly and annual reports (10-Q and 10-K), and presentation slide", "url": "https://www.tradingview.com/symbols/FWB-1P5/documents/", "source_name": "TradingView", "published_at": "2026-07-03T07:10:23", "published_display": "03 Jul 2026 07:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of PAVmed Inc. \u2013 NASDAQ:PAVM", "summary": "This article provides an overview of PAVmed Inc. (NASDAQ: PAVM) focusing on its enterprise value to revenue forward metric. It appears to list financial data and market information through the TradingView platform. The content is primarily a listing of financial data access rathe", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T08:11:52", "published_display": "01 Jul 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc.(NasdaqCM: PAVM) added to Russell Microcap Value Benchmark Index", "summary": "PAVmed Inc. (NasdaqCM: PAVM), a commercial-stage medical technology company, has been added to the Russell Microcap Value Benchmark Index. This inclusion follows its prior addition to the Russell 3000E Index and the Russell Microcap Index. The company operates in medical devices,", "url": "https://www.marketscreener.com/news/pavmed-inc-nasdaqcm-pavm-added-to-russell-microcap-value-benchmark-index-ce7f5fded080ff25", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T13:14:37", "published_display": "29 Jun 2026 13:14", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc.(NasdaqCM: PAVM) added to Russell 3000E Value Benchmark", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmFuaGxVS2JnSG5TV2YwVGZWejlnSXo3OEJWdmxWdE5RUXVISjYxcGlXTGNBUHgxSGJ4TTFjbHI5MFNUdFhQanVDaUNEc3RYLUFtdFQwdzFpX2Frc1Jqdzd6UXFKdGt3RldvRlF3bVg0V3hjN29vajVGVkZTa194OGUxUE9EcVU3MUE5bmd2VTA5UUFyR0J0V3k3U0cxRDJlc1pRVTlQNEREUGVxWVFrY3c1Z3Z3OVk?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed, Inc. Actuals & Estimates (NASDAQ:PAVM)", "summary": "This article provides an overview of PAVmed Inc. (NASDAQ: PAVM) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, financial actuals and estimates, upcoming earnings dates, and past earnings and revenue figures. Th", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:47", "published_display": "26 Jun 2026 03:40", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for PAVmed Inc. (PAVM) stock for 2027, based on analyst opinions. It details the current stock price, historical performance, volatility, market capitalization, and upcoming earnings report. The article also includes frequently as", "url": "https://www.tradingview.com/symbols/NASDAQ-PAVM/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:40:47", "published_display": "25 Jun 2026 14:40", "sentiment": "negative", "sentiment_pct": 18, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed (PAVM) holders re-elect directors, expand ESPP shares and ratify CBIZ", "summary": "PAVmed Inc. shareholders re-elected directors Ronald M. Sparks and Timothy Baxter and approved significant amendments to the Employee Stock Purchase Plan (ESPP), increasing available shares and the annual evergreen limit. Additionally, shareholders ratified CBIZ CPAs P.C. as the ", "url": "https://www.stocktitan.net/sec-filings/PAVM/8-k-pa-vmed-inc-reports-material-event-a905a8c4bac2.html", "source_name": "Stock Titan", "published_at": "2026-06-24T21:09:59", "published_display": "24 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of PAVmed Inc (PAVM), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock has a current price momentum score of 7.15 and is trading between a resistance level of 6.", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/technical", "source_name": "TradingKey", "published_at": "2026-06-23T07:39:25", "published_display": "23 Jun 2026 07:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article analyzes the financial health of PAVmed Inc (PAVM), noting its stable financial status but low operational efficiency. As of June 18, 2026, its financial score is 7.21, ranking 101 out of 203 in the Healthcare Equipment & Supplies industry. The company reported a sig", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/financial-health", "source_name": "TradingKey", "published_at": "2026-06-19T11:10:20", "published_display": "19 Jun 2026 11:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVMZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of PAVmed Inc (PAVMZ), covering its support, resistance, indicators, and moving averages. It notes that relevant data for support and resistance have not yet been disclosed by the company. The analysis indicates a \"Sell\" signal based on ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavmz/technical", "source_name": "TradingKey", "published_at": "2026-06-18T23:40:46", "published_display": "18 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Institutional Confidence", "summary": "This article provides details on PAVmed Inc (PAVM)'s institutional confidence, highlighting its stock price, market cap, and a breakdown of its TradingKey Stock Score, which includes institutional confidence. It lists key institutional shareholders and their shareholdings. The da", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T23:39:03", "published_display": "18 Jun 2026 23:39", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVMZ) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article provides an analysis of PAVmed Inc's (PAVMZ) financial health, focusing on profitability and its balance sheet. However, the report indicates that relevant financial data for key metrics such as cash and cash equivalents, total assets, liabilities, free cash flow, re", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavmz/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T22:40:46", "published_display": "18 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of PAVmed Inc's (PAVM) dividend history and stock split events. It indicates that PAVmed has not distributed any dividends in the past five years. The article also lists several stock split events, all described as \"Merger\" type, with the most re", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T22:40:46", "published_display": "18 Jun 2026 22:40", "sentiment": "negative", "sentiment_pct": 42, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of PAVmed Inc (PAVM), listing major individual and institutional holders and their respective proportions. It also presents a historical overview of institutional shareholding by reporting period, as well as recent shareholder activi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T15:39:45", "published_display": "18 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for PAVmed Inc (PAVM), detailing its current earnings forecast score, analyst ratings, and price targets. It notes that PAVmed Inc has an earnings forecast score of 8.00, ranks 66th in its industry, and has an average price target of $12", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T12:39:45", "published_display": "18 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey attempts to provide a revenue breakdown for PAVmed Inc (PAVM) by business segments and regional contributions. However, the company has not disclosed the relevant financial data. Therefore, the article primarily highlights the unavailability of this s", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T08:39:45", "published_display": "18 Jun 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVMZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "The article discusses the revenue breakdown of PAVmed Inc (PAVMZ) but explicitly states that relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. Therefore, the content highlights the lack of publicly ava", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavmz/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T15:10:13", "published_display": "17 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVMZ) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article provides an overview of PAVmed Inc's (PAVMZ) shareholder structure, highlighting that \"Other\" shareholders account for 100% of the proportional holdings. It also details institutional shareholding data from Q3 2023 to Q3 2025, showing changes in the number of institu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavmz/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T07:10:13", "published_display": "17 Jun 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM Maintains Buy Rating -- Price Target Lowered to $56.00 by Ascendiant Capital", "summary": "Ascendiant Capital has maintained a \"Buy\" rating for PAVmed Inc (PAVM) but lowered its price target from $65.00 to $56.00, representing a 13.85% decrease. Despite the maintained buy rating, GuruFocus indicates that PAVM is significantly overvalued with a GF Value\u2122 of $1.28 agains", "url": "https://www.gurufocus.com/news/8904895/pavm-maintains-buy-rating-price-target-lowered-to-5600-by-ascendiant-capital", "source_name": "GuruFocus", "published_at": "2026-06-08T10:39:19", "published_display": "08 Jun 2026 10:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM - PAVmed Inc Stock Price and Quote", "summary": "This article provides comprehensive stock information for PAVmed Inc. (PAVM), including its current stock price, financial metrics, performance indicators, and recent news and analyst ratings. It also details the company's business activities, focusing on its Lucid Diagnostics an", "url": "https://finviz.com/stock?t=PAVM", "source_name": "Finviz", "published_at": "2026-06-02T16:39:46", "published_display": "02 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPZ1dYQ3MyTGgtVWNsNUtETFl0R3hZWmdFdWhadnR0SGtfSmdBN1JIQ0xaaXd6OU1yTVk1RU1SY0RGUHdpTHdFU2pKUkYyeEw4NFpnWmlBRVJTTXEydzA4Sk9mUS1kQXp4T2tPSi1FUnVuNDdpRUxMalZpYWlGbmQ0NXY2cFB4WGxUb2o0ZTVQazVXcTM2ZkoydXgxTGpnQzFGUmFWTkJ0UQ?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc. (PAVM) Holds Steady Near Support as Slight Dip Signals Consolidation - Intraday Profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNWFFUX29WREgwTV82NnAyQVZVUnNmdDBEaFZnaE1MVExjdkxZVnlPN1pmc2tnbzc2anZfQ204dkZBNE1sdU5Hd0tkX1Y3bDZvaVI5SUoyX1Fhc0lFVGxDOTFuaGRRcFZUbkp1TWR3MTFUZ0pzRXBOb2RoS29iNkljUEZvZzJvcVphMVc0czN3SWM1Rm5jU0QyczZRMDRHQzFHYkhZZlcwUHdIdG1ibUVQTDUtVFU4dGZyWEJGSmFn?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM Technical Analysis & Stock Price Forecast", "summary": "This article provides a technical analysis of PAVmed Inc (PAVM), concluding with a \"Strong Sell\" consensus based on various indicators. It details moving averages, momentum indicators like RSI and MACD, and identifies key support and resistance levels. The analysis highlights tha", "url": "https://intellectia.ai/en/stock/PAVM/technical", "source_name": "Intellectia AI", "published_at": "2026-05-28T01:38:45", "published_display": "28 May 2026 01:38", "sentiment": "negative", "sentiment_pct": 8, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM PE Ratio & Valuation, Is PAVM Overvalued", "summary": "This article analyzes the valuation of PAVmed Inc (PAVM), concluding that it is currently overvalued. Based on relative valuation methods, PAVM's fair price is estimated to be between $2.40 and $5.27, compared to its current price of $6.35, indicating a 20.39% overvaluation. The ", "url": "https://intellectia.ai/en/stock/PAVM/valuation", "source_name": "Intellectia AI", "published_at": "2026-05-22T19:09:23", "published_display": "22 May 2026 19:09", "sentiment": "negative", "sentiment_pct": 32, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM|PAVmed Inc|Price:6.390|Chg%:0.04", "summary": "PAVmed Inc (PAVM) shows stable fundamentals, industry-leading ESG disclosure, and high growth potential, though its valuation is only fairly valued within its industry. Analyst ratings are \"Buy\" with a target price of $40.50, despite recent weak market performance. The company sp", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-pavm", "source_name": "TradingKey", "published_at": "2026-05-22T12:08:58", "published_display": "22 May 2026 12:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Maintains Target Price $16", "summary": "Maxim Group has reiterated its Buy rating for PAVmed (PAVM.US) and maintained its target price at $16. This indicates continued confidence from the analyst firm in the company's prospects.", "url": "https://www.moomoo.com/news/post/70260820/maxim-group-maintains-pavmed-pavmus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-05-21T11:39:22", "published_display": "21 May 2026 11:39", "sentiment": "positive", "sentiment_pct": 78, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: PAVmed Q1 2026 sees restructuring gains", "summary": "PAVmed Inc. (PAVM) reported mixed financial results for Q1 2026, featuring significant capital structure improvements from a recent recapitalization despite a stock decline. The company is actively relaunching its medical device portfolio, pursuing new assets, and advancing its s", "url": "https://m.in.investing.com/news/stock-market-news/earnings-call-transcript-pavmed-q1-2026-sees-restructuring-gains-93CH-5419116?ampMode=1", "source_name": "Investing.com India", "published_at": "2026-05-20T23:11:49", "published_display": "20 May 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Q1: cancer test and implantable monitor push toward coverage, FDA", "summary": "PAVmed reported Q1 2026 financial results with a GAAP net loss of $7.0 million, and non-GAAP adjusted net loss of $1.9 million, while cash and equivalents increased to $6.5 million. The company's subsidiary, Lucid Diagnostics, generated $1.3 million in EsoGuard revenue and secure", "url": "https://www.stocktitan.net/news/LUCD/pa-vmed-provides-business-update-and-reports-first-quarter-2026-th0qvi03ua1b.html", "source_name": "Stock Titan", "published_at": "2026-05-19T06:40:13", "published_display": "19 May 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/pavmed-inc-pavm-q1-2026-230154477.html", "source_name": "GuruFocus.com", "published_at": "2026-05-15T23:01:54+00:00", "published_display": "15 May 2026 23:01", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed (PAVM) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/7721d31f-8283-3dd3-98c4-aff0fcc13c2e/pavmed-%28pavm%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-15T15:36:59+00:00", "published_display": "15 May 2026 15:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed (PAVM) Q4 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/841b463c-3916-3223-a706-0fd27ecc3451/pavmed-%28pavm%29-q4-2025.html", "source_name": "Motley Fool", "published_at": "2026-05-15T15:36:20+00:00", "published_display": "15 May 2026 15:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/pavmed-inc-pavm-reports-q1-131502431.html", "source_name": "Zacks", "published_at": "2026-05-15T13:15:02+00:00", "published_display": "15 May 2026 13:15", "sentiment": "negative", "sentiment_pct": 42, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNNnkwNXhpZmVHRHZBWDhoQzB1SWxaQkRUbDJ4NEllRm9IQm1VclJTZkVKSmloYUQta2ZPTXBGUWNaUjhicUs2T3ltYWJOV3o2b0JsdEt2YUw0cC1neFdBT2ZubjZNa2J5Zk5NeTdyd3hvclNoUVlUcUVrRGNoUG51cmVqQ1lWX2t3ZDlFaDh2YTlYUGxBcFhIdTRfQWQ3UXZNQ2ZFMWlIbmdtcjRJVFZ4Vlc2c1RSVGM0eGYzT01WQWxJbUd1X3BrZFpwMjM3M01reWc?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOVGkyQno5anU4TkRPQW03WWdXT1UtaWcxX3NGdnFVZlFINHE3clRtb3hpTFlxQVhxd1ZzNVd2bWNoY1NXblNQNTlCMXRRVkp4azh3TlkxV2Znb1BNWEw1Qm1fMHhnQ05RVXlXQTJYX01VendtNVZPc2FwUlIzbGExckJjbHhjNmM3cDJVUUYxdw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNbXpmeHlSbks3aVlPMF9FNjQ5UFdGY2huU2tNc2Q1emFkX2pvd0RjZWNMQ2hSNy1PYmFrSDVYd2szV3c0WVBCLXZZQ0Z2N2w5TjdsUHdQV2szdzZab1pyUWx3YUdpbFhkck1oVFp3Rm04aHNJWnN3TWc0SHRhRzd3WFdDVi0wQU9CbXpBQzVZX2RWUQ?oc=5", "source_name": "TipRanks", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Shares Soar Amid Strategic Developments and Market Reactions", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE5UdEpqLU1JdGUzc0dvTWxJdzUwX3hzV01fU2RxRUtqUUIwd3dlZDVsMXdXbnVhSmhqREJVSnpPeDJoQTdYc3YzeHF6bVpsLW80SDRGT2ZMRi1FaDdZd2k5bjVOMzFCZ0N1RUlKN3hGWV8wZGc4?oc=5", "source_name": "timothysykes.com", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should you chase the rally in PAVmed stock that quadrupled on Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNdC1fc3FxQlRqWWJGamtoRy05Q3hacHNjY2loN3N5WWxvWkxYdGJUUGRuSlJaWk9zcy1xdWdLaUV0Q0pZMmhCZzJZbGpnLUJ6WVZMdVFBUzRmWkRVVW0xZnQ2X3VCdHpwOVZ3NTFPdHZNdjc0ekE0NjBTcVpQT0ZFaVZpUmItUXVsZ1RGQ1dOcFFJbThVSE1VaF9ZX2kyNlB4RTZDSlRLcFFObGZXWFlTOQ?oc=5", "source_name": "Invezz", "published_at": "2026-01-21T08:00:00+00:00", "published_display": "21 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Announces Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNdWFwWWZQRUtOUndpYUpMZzh6anJlOUxJUGtLdHVHRjhCZVJLaFNfN3k5SDJReDNfOUlsNjdMV0hoYmZlN3BKYWhranhCWDVFQ2xhbzJPdEJ6OGZwdXh3ckE3TndfYlBkSzVUM2NaWDhQbnA3RUVaSlU3SEtPSHZwZk5zUjYyQm1HRkowdnhva0hjR0JacHRn?oc=5", "source_name": "PR Newswire", "published_at": "2025-12-30T08:00:00+00:00", "published_display": "30 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed stock drops after announcing 1-for-30 reverse split", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQTmpVUXlSWnZXcG9EeWVtV1Zzb0ZQTFJVQ21KQ3dnNF84cml5MHM2c3BoUzVUOXNtRWo5RUg3X280TlhaMnV3ekxqbzU1anVYYncxVUlMN09NdDVpRjhzZ2RUMEE4aGFGOW9renpkb0twSjlDSUNYNE5wb0ZkbUo0Um1Za0x6YlVGZEs0Z2s2Q2RGZGJ1SncxcHVDSlVLekFBUUQ4SVE4M0J3M2FETnVnaEhvZE1iT0xMZ2c?oc=5", "source_name": "Investing.com", "published_at": "2025-12-30T08:00:00+00:00", "published_display": "30 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is PAVmed (NASDAQ:PAVM) Using Debt Sensibly?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZ1U2TWRSQzFTcVh2WXh6WkJiTmpoQTZFNndhcXpNTUFQcnN3Tk1uaXJQeExZZl92RDJaaFM1cE1sbkdwaXJfaklfclU0R0JrVmlRN0phNFlVTnpaNUo4bk1YeU4xYU1oX2cxMkU3a1dmeXh0bHhBTFZreWF6WlhHTzM0U2dDSUpoaE9fS2JMMW9YeGNCYXNNQ2ozRzVTTWdlbGh4bFc0TkFsbnfSAbABQVVfeXFMT25MaGdfZEJpLVF2dWViWVc4Mnk0blFNX2tVaFkzVnk2XzRZdGpaZS1kcjE2R05LQzR4REFVcGFSTDVqV0RsQ24zVjRQbWJPSXQ5ZjRjU0JMWW9BSHJhMjhCTjhNUlVGeVZMYktUN2F3emtiRDhpWmdaRFFJRkxTcEJ0ejQxOENWMFFXWDFLZFd1QzVZeUd1OXlKb3FYSFJpNS01OXJoQ2p2Z0tMODBuSGI?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-18T08:00:00+00:00", "published_display": "18 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed (PAVM) Upgraded to Strong Buy: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQckh5WWQ0T2lJTm4zUTNtbVA4RFpCRXYzVGpHWXI1NHNsMmJfdTBxNFIzb0R6Ql9HVnJjSzdrYVlWM3d6c3Q5R3hrbnU2UFNkUzNKYi1oQnA3QkloZkV1c0U4emJZTVBWbGs4dmFiUFZTZHRaZ29xbjBkNkwyYjRiVVpuYw?oc=5", "source_name": "Market source", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwJBVV95cUxQb0tUdlFLZHNlR1dCb0hsTHJQVTMzQjdTSWl3bnR4T1VZQi13ajdRQTVUVUFQRFBabzBLV1JERi1VWjhIVHc4elJHOTRmM2xxTDVxTGlMdC02SWNoZDRNaG1ucnd2Z01yNTA2X0RTSEN4MVA3SHRkRFJqVFdwZVI1UWJtWHB4RG1BNlByNEtGTDFkaHNlSkpfWTZKOTA5YUlnX3hULXhqYjlZTFFRZmhNQnVOZzcyd2puUHBBSE90RkhEak4zOHVhMG9fbS1OQlRTZ2tSQkJ6dlVzM29idmpPOWhvNUxGRFNidTdyelZKWnd0UF93dHhlb09lWFpOYlBLUzRGbDlURkxpeTQ5N095dGlOS3M3S0kyenJHbVp5dUdCME9XcGJqVk5aNA?oc=5", "source_name": "PR Newswire", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQVmdnZ1lZUUpXcjhBOEtHb2d0anZTS0VxQWhLRlpld2RmTE1XNlZ0c00xRkxBak1ndmpPZWd1QmFOeEJuTVhYSnkyblRCTVFJaGVCa24wdC1zcmFOQkVNa2NGRXBCd2JsbWNOR1JFWmc3ZGtzRHNrdzhPRGJYSlNtRC1PUUNXNEdhS1c1UUpUbENESS00NDlUcHVtT3B1YzNoNGRzelBOWFJPUC1KV2IxNmdMNHV6YXZzVHF1YUY5b3hNQ29VX2ZXTWVtWGtQNlFhWHplUHJR?oc=5", "source_name": "PR Newswire", "published_at": "2023-12-04T08:00:00+00:00", "published_display": "04 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pavmed (PAVM) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9PTVpfWEk3Wmo0Q0xjTGFqNi0wQm0wZkJHRm9UV1BYcEtScGNZU01CaEtrRlNEU1dkQWZRenNRQVZWdWdSSmwwT1dfSU1CUQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-09-12T01:53:59+00:00", "published_display": "12 Sep 2020 01:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PAVM Stock Price and Chart \u2014 NASDAQ:PAVM", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE4xaVl2aXA4cnEtTGNaSUtTTUNhZW9GTEo3X1lYZzAzYndkQTRBVjRUdmtVcjlPYk5nQUVtQ25fNnFUZTZxcnJKYW0tdTNvanVoSWNjTC1MTk1IZFFS?oc=5", "source_name": "TradingView", "published_at": "2017-08-04T22:59:47+00:00", "published_display": "04 Aug 2017 22:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 97, "total_relevant": 61, "sentiment_summary": {"positive": 9, "negative": 9, "neutral": 43, "score": 49, "total": 61, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 74, "events": [{"event": "general", "label": "Market update", "weight": 12.65, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 12.59, "count": 25}, {"event": "analyst", "label": "Analyst action", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 2.0, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 9, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 5.6, "latest_week": "2026-07-10", "one_week_move": -1.9, "four_week_move": 12.0, "twelve_week_move": -38.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.814914, "market_dynamics_buy_signal": false, "relative_strength": -53.715647, "fair_value_gap": -86.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 41.4362, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.9% over one week, +12.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingKey", "count": 12}, {"label": "Market source", "count": 11}, {"label": "TradingView", "count": 8}, {"label": "PR Newswire", "count": 4}, {"label": "Stock Titan", "count": 3}, {"label": "StockStory", "count": 2}, {"label": "Intellectia AI", "count": 2}, {"label": "Motley Fool", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 50}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 25}, {"label": "Market update", "count": 23}, {"label": "Analyst action", "count": 6}, {"label": "Deals and strategy", "count": 3}, {"label": "Balance sheet", "count": 2}, {"label": "Guidance", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "50", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.9% over one week, +12.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to book forward of PAVmed Inc. \u2013 NASDAQ:PAVM"}], "updated_at": "2026-07-17T04:21:56.148032+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}